By Joshua Kirby. Novartis AG said Thursday that it will invest $250 million in research against malaria and neglected tropical diseases, or NTDs. As part of the five-year commitment, the Swiss drugmaker will invest $100 million to advance research and ...
from Google Alert - health https://ift.tt/c9mpDxU
via IFTTT
0 comments:
Post a Comment